Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS3620218 A
Tipo de publicaciónConcesión
Fecha de publicación16 Nov 1971
Fecha de presentación25 Ago 1969
Fecha de prioridad31 Oct 1963
Número de publicaciónUS 3620218 A, US 3620218A, US-A-3620218, US3620218 A, US3620218A
InventoresEdward Emil Schmitt, Rocco Albert Polistina
Cesionario originalAmerican Cyanamid Co
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Cylindrical prosthetic devices of polyglycolic acid
US 3620218 A
Imágenes(1)
Previous page
Next page
Descripción  (El texto procesado por OCR puede contener errores)

United States Patent 72] Inventors [21 Appl. No. [22] Filed [45] Patented [73] Assignee [54] CYLINDRICAL PROSTHETIC DEVICES 0F [51] .lnt.Cl. .4 ..A6lb 17/11 [50] Field olSearch 128/334. 335.5; 3/D1G. 1

[56] References Cited UNITED STATES PATENTS 2,127,903 8/1938 Bowen 128/334 2,428,918 10/1947 Miller 128/334 2,676,945 4/1954 Higgins.... 260/783 X 3,155,095 11/1964 Brown 128/334 3,297,033 1/1967 Schmitt et a1 128/3355 3,463,158 8/1969 Schmitt et a1 128/334 Primary Examiner- Dalton L. Truluck Attorney-Samuel Branch Walker ABSTRACT: Polyhydroxyactic ester, also called polyglycolic zg fi g gg g g" acid (PGA), has surgically useful mechanical properties as a a solid prosthesis, such as reinforcing pins. screws, plates, or [52] U.S.Cl 128/334 R, cylinders. On implantation, in living mammalian tissue, the

3/D1G l polyglycolic acid is absorbed, and replaced by living tissue.

div-WA! 4-4.". afll'u' puma-m2; Ewaawmowunw* 1 CYLINDRICAL PROSTHETIC DEVICES OF POLYGLYCOLIC ACID CROSS-REFERENCES This application is a continuation-in-part of application Ser. No. 608,086, Jan. 9, 1967 now U.S. Pat. No. 3,463,158, Aug. 26, 1969, Polyglycolic acid Prosthetic Devices" and Ser. No. 320,543, filed Oct. 31, 1963 now U.S. Pat. No. 3,297,033, Jan. 10, 1967, Surgical Sutures."

FIELD OF INVENTION This invention relates to absorbable surgical structural elements of polyhydroxyacetic ester hereafter called polyglycolic acid (PGA PRIOR ART The use of submucosal tissue and ribbons therefrom internally is described in such patents as U.S. Pat. No. 2,167,251, Rogers, Surgical Tape of Submucosa Tissue," July 25, 1939, U.S. Pat. No. 2,143,910, Didusch, "Ribbon-Gut and Method of Using the Same," Jan. 17, 1939, and U.S. Pat. No. 2,127,903, Bowen, Tube for Surgical Purposes and Method of Preparing and Using the Same,.Aug. 23, 1938.

U.S. Pat. No. 3,155,095, A. M. Brown Anastomosis Method and Means shows an internal and external absorbable coupling for the joining of vascular vessels.

SUMMARY Definitions in the textiletrades are frequently somewhat ambiguous. For purposes of the present application, certain terms are defined:

A "filament" is a single, long, thin flexible structure of a nonabsorbable or absorbable material. It may be continuous or staple.

Staple is used to designate a group of shorter filaments which are usually twisted together to form a longer continuous thread.

An absorbable filament is one which is absorbed, that is digested or dissolved, in living mammalian tissue.

A threa is a plurality of filaments, either continuous or staple, twisted together.

A strand" is a plurality of filaments or threads twisted, plaited, braided, or laid parallel to form a unit for further construction into a fabric,.or used per se, or a monofilament of such size as to be woven or used independently.

A solid prosthetic device" is a thin solid sheet, or plate, or tube, which may be split, or bar, or nail, or screw, or pin or other solid shape which has inherent mechanical strength in compression, bending and shear to act as a solid discrete surgical reinforcing element, and has at least one dimension greater than 2 millimeters, and which may have a dimension as great as about 200 millimeters, or as required, to fit into or adjacent to and furnish mechanical support and reinforcement to a bone, or bones, or gland, or organ, for support during a healing process.

The size and shape of the prosthetic devices, or protheses, is controlled by usage. For example, in the human body, in the case of a bone fracture, a pin is used to reinforce a bone, and is of such a size as to be a tight driving fit into a central portion of the bone, or a hole drilled into a bone. Such a pin can be from about 1/ 16-inch diameter and 16-inch length for finger bones, or for children, up to 1 1/4-inch diameter and, 6-inch length to reinforce the femur, or thigh bone of large adult humans, or even larger for valuable race-horses or other mammals.

The support may be in part directive of growth, as for example in nerve tissue, which grows slowly, and as a result has regeneration impaired by the more rapid growth of scar tissue which can block the growth of the nerve tissue. With a wraparound sheath of PGA sheet, or a split or solid tube used to support, place, hold and'protect; regeneration of nerve tissue and function is greatly aided. Other factors may inhibit regeneration of nerve tissue or function, but with the exclusion of scar tissue, such other factors may be separately treated. PGA is particularly useful in splicing nerves because PGA is completely dissolved in tissue and leaves minimal or no residual scar tissue from the PGA.

For different purposes and in different types of tissue the rate of absorption may vary but in general an absorbable prosthesis should have as high a portion of its original strength as possible for at least 3 days, and sometimes as much as 15 days or more, and preferably should be completely absorbed by muscular tissue within from 45 to days or more depending on the mass of the cross section. The rate of absorption in other tissues may vary even more.

In common with many biological systems, the requirements are not absolute and the rate of absorption as well as the shonterm strength requirement varies from patient to patient and at different locations within the body, as well as with the thickness of the section of PGA.

ThePGA may be formed as tubes or sheets for surgical repair and may. also be spun as thinfilaments and woven or felted to form absorbable sponges or absorbable gauze, or used in conjunction with other compressive structures as prosthetic devices within the body of a human or animal where it is desirable that the structure have short term strength, but be absorbable. The useful embodiments include tubes, including branched tubes or Tees, for artery, vein or intestinal repair, nerve splicing, tendon splicing, sheets for tying up and supportingdamaged kidney, liver and other intestinal organs, protecting damaged surface areas such as abrasions, particularly major abrasions, or areas where the skin and underlying tissues are damaged or surgically removed.

The medical uses of PGA include, but are not necessarily limited to:

A. Pure PGA 1. Solid Products, molded or machined a. Orthopedic pins, clamps, screws and plates b. Clips (e.g., for vena cava) c. Staples d. Hooks, buttons and snaps e. Bone substitute (e.g., mandible prosthesis) f. Needles g. Nonpermanent intrauterine devices (antispermocide) h. Temporary draining or testing tubes or capillaries i. Surgical instruments j. Vascular implants or supports k. Vertebral discs I. Extracorporeal tubing for kidney and heart-lung machines Fibrillar Products, knitted or woven, including velours a. Burn dressings b. Hernia patches c. Absorbent paper or swabs d. Medicated dressings e. Facial substitutes f. Gauze, fabric, sheet, felt or sponge for liver hemostasis g. Gauze bandages h. Dental packs Miscellaneous a. Flake or powder for burns or abrasions b. Foam as absorbable prosthesis c. Substitute for wire in fixations d. Film spray for prosthetic devices B. PGA in Combination with other Products b 1. Solid Products, molded or machined a. Slowly digestible ion-exchange resin b. Slowly digestible drug release device (pill, pellet) c. Reinforced bone pins, needles, etc. 2. Fibrillar Products a. Arterial graft or substitutes b. Bandages for skin surfaces c. Burn dressings (in combination with other polymeric The synthetic character and hence predictable forrnability and consistency in characteristics obtainable from a controlled process are highly desirable.

The most convenient method of sterilizing PGA prostheses is by heat under such conditions that any micro-organisms or deleterious materials are rendered inactive. A second common method is to sterilize using a gaseous sterilizing agent such as ethylene oxide. Other methods of sterilizing include radiation by X-rays, gamma rays, neutrons, electrons, etc., or high-intensity ultrasonic vibrational energy or combinations of these methods. The present materials have such physical characteristics that they may be sterilized by any of these methods.

PGA can be considered as essentially a product of polymerization of glycolic acid, that is hydroxyacetic acid, which in simplified form is shown by the equation:

polyhydroxyaeetlc ester (PGA) g hydroxyacetie acld the cyclic dimeric condensation product formed by dehydrating hydroxyacetic acid. During polymerization of glycolide, the ring is broken and straight-chain polymerization occurs.

Small quantities of other materials may be present in the chain, as for example, d,l-lactic acid, its optically active forms, homologs, and analogs. In general plasticizers tend to interfere with crystallinity, orientation, etc. and weaken the prosthesis but are useful for sponges and films. Other substances may be present, such as dyes, antibiotics, antiseptics, anaesthetics, and antioxidants. Surfaces can be coated with a silicone, beeswax, and the like to modify handling or absorption rate.

The polymerization of glycolide occurs by heating with or without a catalyst, or may be induced by radiation such as X- rays, gamma rays, electron beams, etc. Polymers may also be obtained by condensing glycolic acid or chloraacetic acid with or without a catalyst under a variety of conditions. Good moldable objects or fibers are most readily obtained when the melt viscosity at 245 C. is about 400 to about 27,000 poises.

Polyhydroxyacetic esters have been described in U.S. Pat. No. 2,668,162, Lowe, Preparation of High Molecular Weight Polyhydroxyacetic Ester," and U.S. Pat. No. 2,676,945, Higgins, Condensation Polymers of l-lydroxyacetic Acid."

The processes described in the above two patents can be used for producing PGA from which prostheses may be made. Additives such as triphenylphosphite or Santo-Nox, a disulfide aromatic phenol, can be added as color stabilizers.

DRAWINGS FIG. 1 shows a spliced artery having an internal sleeve with slightly tapered ends, with a sewn splice.

FIG. 2 is a cross section of a spliced artery having an internal sleeve with expanded ends.

FIG. 3 shows a prosthetic sleeve formed of a unitary coupling of solid polyglycolic acid with slightly expanding ends to aid in holding a blood vessel about the sleeve.

FIG. 4, shows the sleeve of FIG. 12 in use in which an external spring clip of solid polyglycolic acid holds the ends of the blood vessel together.

FIG. 5 shows the sleeve of FIG. 12 in which two expandable annular clips are used to hold the ends of the blood vessel approximated.

PGA for the construction of the prostheses shown in the drawings can be produced as set forth in the following examples, in which parts are by weight, unless otherwise clearly indicated.

EXAMPLE 1 One hundred parts of recrystallized glycolide (melting point 85.0 to 85.5" C.) are intimately mixed with 0.02 part of methoxyacetic acid, 0.03 part of phenoldisulfide (Santo-Nox), and 0.03 part antimony trifluoride. Separate glass tubes are each charged with approximately 20 grams of the mixture, deoxygenated by repeated evacuation and argon purging, then sealed under vacuum and heated to 185 to I C. for 4 v1 hours. On cooling a white opaque tough PGA is produced in a 97.5 percent yield with a melt viscosity at 245 C. of 5,000 poises. The polymer is reheated and spun into filaments at a temperature of about 230 C. at a speed of about feet per minute. The filaments produced are cooled, then drawn at about 55 C. When drawn to 5 times the original length a strong tough filament is produced. The dry filaments are in condition for use.

EXAMPLE 2 The polymer of the preceding example is formed into a plurality of smaller filaments, seven of which are twisted into a polyfilamentary strand, which is sterilized and used following the techniques of examples 1.

Because it is a synthetic polymer the methods of forming are more versatile than in starting with naturally occurring materials.

EXAMPLE 3 lnto a suitable reaction vessel there is charged 400 parts of a commercial glycolic acid which is then heated from room temperature to about 200 C. over a period of about 4 hours. When the pot temperature has reached l85 C., the pressure of the system is reduced from atmospheric pressure to 15 mm. of Hg, causing the water of condensation and/or esterification to distill off. The residue is allowed to cool and is pulverized into about 280 parts of a powder which is then added in small increments to a suitable pyrolysis chamber maintained at a temperature of about 250-285 C. at a pressure of less than 15 mm. of Hg. The distillate which weighed about 238 parts is dissolved in a minimum amount of hot ethyl acetate, and after decolorizing and purifying with active carbon, the distillate is recrystallized from the above solution to provide parts of product having a melting point of about 82.5-84.0 C. The infrared spectrum confirms that the product is substantially pure glycolide.

The glycolide thus prepared is polymerized in the presence of an alcohol free of nonbenzenoid unsaturation and free of any reactive groups other than alcoholic hydroxy groups and in the presence of SnCl,-2H,O.

A heavy walled glass tube having a bore of about threetenth inch and sealed at one end is charged with 3 parts of the substantially pure glycolide composition, 0.04 part of a 0.l percent ether solution of SnCl,-2H,O (about 0.0013 percent of SnCl,-2H,O based on the weight of the substantially pure glycolide composition), 0.0166 part of lauryl alcohol (0.346 mole percent based on the moles of the substantially pure glycolide composition), and a magnetic steel ball five thirtysecond inch in diameter. The tube is evacuated and purged with argon. The tube is evacuated again to a vacuum of less than 1 mmsof Hg and the top is sealed. The reaction tube is placed in a vertical position in a closed glass chamber throughout which dimethyl phthalate is refluxed at 222 C. The boiling point of the dimethyl phthalate is controlled by decreasing the pressure of the system. At periodic intervals after melting, the viscosity of the reaction mixture is measured by raising the steel ball by means of a magnet and measuring the rate of the fall of the ball in sec./in. Ninety minutes after the melt is first achieved, the ball drop time is 550 sec./in. or about 7,200 poises, and after 120 minutes, the ball drop time is 580 sec./in. or about 7,600 poises.

The PGA thus produced is spun into 0.002-inch diameter fibers and used to form strands.

Additional PGA, similarly produced is used to form sheets, or tubes. These are wrapped around nerves, traumatically severed, to protect such nerves from invasive scar tissue growth, while the nerve is regenerating.

Also the PGA so produced is fabricated into the prosthetic devices shown in the drawings. The PGA may be moulded or machined or extruded to a desired configuration.

In FIG. I is shown an artery 37 which is joined together over a tapered end PGA tube 38 which fonns a stent about which the ends of the artery wall are joined by a suture splice 39. The tapered end is easier to insert in the artery.

In FIG. 2 the artery walls 40 are joined together over a flared end PGA tube 41 and the ends are joined by a suture splice 42.

FIG. 3 shows the flared end PGA tube 41.

In FIG. 4 is shown a blood vessel 43, the ends of which are each separatedly placed over the end of a flared PGA tube and which blood vessel is held in place with the ends adjacent to permit healing by a PGA spring clip 44. PGA, such as produced in the above example 3, shows an Izod impact strength of 0.14 ft.-lbs. per inch width or greater. It may be heated and fonned into a desired shape which shape is retained on cooling, and by shaping as a flat spring clip, can be used to hold together the walls of a blood vessel 43 until natural regeneration takes place.

In FIG. 5 is shown a similar splice of a blood vessel 45 but in which the ends are held together by an annular clip 46 of molded PGA. Such annular clips are well known for the attachment of radiator hoses to radiators in automobiles and the attachment of other flexible tubing to connectors. By a suitable choice of diameter and shape, as is well known in the industry, the radial compression at all points about the periphery may be caused to be approximately uniform and within a desired range. This is important in the splicing of blood vessels as it is desired to hold the blood vessel in position during regeneration, but yet not hold the vessels so tightly that necrosis sets in because of an impaired blood supply to the vessel walls.

While disclosed primarily for blood vessels, or vascular vessels, because jointure of such vessels is of greatest interest at present, obviously the same techniques and hollow splice cylinders can be used on any of a variety of vessels in the body of man or animals. Such tubes include fallopian tubes, spermatic ducts, bile ducts, ureters, sinus tubes, eustachian tubes, tear ducts, or for absorbable drain tubes in body cavities, or where a splice or joindure is required in any body tube. The size of the hollow cylinder is preferably such that the lumen, or internal diameter is about that of the tube being joined. The ends of the cylinder are conveniently tapered, so that the ends are readily insertable in the body tube, and for blood vessels so that a minimum of tubulence is induced in flowing blood, and hence thrombus formation is minimized. The PGA cylinder appears to be essentially nonthrombogenic.

The splice PGA cylinder normally is of uniform diameter, as usually the ends of the vessel to be spliced are the same. The diameters may be made different to join vessels of different sizes as may' occur where a splice is'to'be made between vessels not normally joined. T or Y-joints can be formed by molding or machining, with the various openings of a desired size, with the PGA protheses to be completely covered by the vessel walls. As the PGA protheses is absorbed, the vessel walls must grow together without defects.

Also because of the tremendous strength of the solid PGA, a surgical needle can be formed on the end of a PGA suture by either fusing the PGA of the suture, or molding additional PGA onto the suture end, the needle being bent and pointed as may be surgically preferred for a specific surgical procedure. The ends or edges of monocomponent or bicomponent fabrics containing PGA may be rendered rigid by moulding such edges, with or without additional solid PGA to a desired configuration. It is often easier to insert and retain a flexible fabric prosthetic tube if the end of the tube is of a size and shape to be inserted into the severed end of a vessel.

The drawings above are illustrative only of embodiment of the present invention in which various prosthetic devices are incorporated into the human body to aid impaired functions of natural elements. From the above drawings and descriptions, it will be obvious to those skilled in the art that many other modifications may be adapted for particular injuries or ills to which the flesh is heir.

The finding that polyglycolic acid, abbreviated PGA, is absorbable in living tissue, and has marked mechanical strength, as a fiber or solid, including sheet, and hence can be used as an element in, or as, a surgical prosthesis, is most unexpected and unpredictable.

Following the method set forth in the American Society for Testing and Materials, 1969 Books of Standards, Part 27, PlasticsGeneral Methods of Testing, Nomenclature, ASTM, 1916 Race St., Philadelphia, Pa. 19103, May 1969, procedure 709-66 at page 303 to 310, (procedure B); a flexure strength of about 40,000 pounds per square inch and a flexure modulus of 1.2 to l.4 l0 pounds per square inch is developed by the solid bars of PGA. For an unfilled plastic these values are spectacularly high. It is even more remarkable that such highstrength values are developed by a polymer that is absorbable by living mammalian tissue.

Catgut, or regenerated collagen has in the past been used for tissue emplacement, but with collagen, as the collagen is absorbed, a fibrotic tract replaces the collagen, so that in effect scar tissue remains at the site of the emplanted collagen for many years, in many instances for life. Some patients are allergic to collagen. PGA is not a protein, has no amino acids, and has given no evidence of allergic reactions in thousands of implants. With the present PGA prostheses, the PGA is completely absorbed, and a minimal or no trace of the inserted matter remains after a comparatively short period. This complete absorption, without residual fibrotic tissue, is unique, and an important contribution to surgery.

We claim:

I. An absorbable prosthesis for the anastomosis of vessels in the tissue of a living mammal consisting essentially of a hollow cylinder of polyglycolic acid, having an inner diameter approximately the same as the inner diameter of the subject vessel, and a smooth outer surface of a diameter which is insertable in said vessel when stretched, whereby one end of a vessel from traumatic or surgical severance may be emplaced over each end of said cylinder, and fixedly positioned thereon, said cylinder being open to and permitting the flow of body fluids, and being absorbable by living mammalian tissue within a few weeks.

2. The absorbable prosthesis of claim I in cooperative eonfiguration with at least one circular cooperative clamp, whereby in assembled relationship, with a vascular vessel end on each end of said cylinder, the vascular vessel ends are uniformly positioned and retained on said cylinder, tightly enough to avoid substantial slippage, and loosely enough to permit circulation into the vessel ends, and hence avoid necro- SIS.

3. The absorbable prosthesis of claim 2 in which the said cooperative clamp is a single split ring, with inward tension sufficient to hold the ends of said vascular vessels, when positioned over said vessels in place over said hollow cylinder.

4. The absorbable prosthesis of claim 2 having two circularly bent rod clamps, said clamps having radii of curvature such that the vascular vessels are held against the hollow cylinder with approximately uniform pressure, around the periphery of said cylinder sufficiently tight to retain the vascular vessels during regeneration, but loosely enough to avoid necrosis.

5. A method of anastomizing two vessels in living mammalian tissue comprising inserting one end of a hollow cylinder of polyglycolic acid having an inner diameter of ap-

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US2127903 *5 May 193623 Ago 1938Davis & Geck IncTube for surgical purposes and method of preparing and using the same
US2428918 *12 Sep 194414 Oct 1947Grover C MillerAnastomosis ring
US2676945 *18 Oct 195027 Abr 1954Du PontCondensation polymers of hydroxyacetic acid
US3155095 *7 Feb 19613 Nov 1964Brown Adolph MAnastomosis method and means
US3297033 *31 Oct 196310 Ene 1967American Cyanamid CoSurgical sutures
US3463158 *9 Ene 196726 Ago 1969American Cyanamid CoPolyglycolic acid prosthetic devices
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US3883901 *27 Nov 197320 May 1975Rhone Poulenc SaMethod of replacing or repairing the body with bioresorbable surgical articles
US4032993 *25 Jun 19755 Jul 1977Rhone-Poulenc IndustriesCopolyester of succinic and oxalic acids, sutures
US4243775 *13 Nov 19786 Ene 1981American Cyanamid CompanySynthetic polyester surgical articles
US4275813 *4 Jun 197930 Jun 1981United States Surgical CorporationCoherent surgical staple array
US4317451 *19 Feb 19802 Mar 1982Ethicon, Inc.Plastic surgical staple
US4379138 *28 Dic 19815 Abr 1983Research Triangle InstituteBiodegradable polymers of lactones
US4443895 *9 Jul 198224 Abr 1984American Hospital Supply CorporationFor use in restraining an animal heart valve against distortion
US4503568 *25 Nov 198112 Mar 1985New England Deaconess HospitalProsthetic arterial connector
US4523591 *22 Oct 198218 Jun 1985Kaplan Donald SPolymers for injection molding of absorbable surgical devices
US4650488 *16 May 198417 Mar 1987Richards Medical CompanyBiodegradable prosthetic device
US4670286 *26 Dic 19852 Jun 1987Allied CorporationCoating by controlled dipping with bioresorbable, vasotropic solution
US4674506 *29 Nov 198423 Jun 1987Kirk AlcondSurgical anastomosis stent
US4744365 *22 Sep 198717 May 1988United States Surgical CorporationTwo-phase compositions for absorbable surgical devices
US4808351 *25 Mar 198528 Feb 1989American Cyanamid CompanyProcess for manufacturing a molded prosthetic device
US4841968 *26 Sep 198627 Jun 1989Southern Research InstituteAntithrombotic/thrombolytic suture and methods of making and using the same
US4863457 *22 Abr 19885 Sep 1989Lee David ADrug delivery device
US4871365 *24 Dic 19863 Oct 1989American Cyanamid CompanyPolyglycolic acid, trimethylene carbonate linkager
US4873977 *11 Feb 198717 Oct 1989Odis L. AvantStapling method and apparatus for vesicle-urethral re-anastomosis following retropubic prostatectomy and other tubular anastomosis
US4913903 *10 Abr 19893 Abr 1990Alza CorporationPolyorthoesters
US4997440 *10 Ago 19905 Mar 1991American Cyanamid CompanyVascular graft with absorbable and nonabsorbable components
US5124103 *2 Ago 199023 Jun 1992United States Surgical CorporationGlycolide-rich polymer dispersed in matrix of lactide-rich polymer; nonbrittle, tensile strength, high distortion temperature, hot-wet creep resistance
US5160341 *8 Nov 19903 Nov 1992Advanced Surgical Intervention, Inc.Resorbable urethral stent and apparatus for its insertion
US5180392 *15 Nov 199019 Ene 1993Einar SkeieAnastomotic device
US5234006 *18 Ene 199110 Ago 1993Eaton Alexander MAdjustable sutures and method of using the same
US5331975 *2 Mar 199026 Jul 1994Bonutti Peter MFluid operated retractors
US5354305 *17 Dic 199211 Oct 1994United States Surgical CorporationNerve repair device
US5403347 *2 Mar 19944 Abr 1995United States Surgical CorporationBlock copolymer of glycolic acid with 1,4 dioxane-2-one and 1,3 dioxane-2-one; clips, staples, monofilament sutures, pins, screws, prosthetic devices, anastomosis rings and growth matrices
US5425739 *17 Dic 199220 Jun 1995Avatar Design And Development, Inc.Anastomosis stent and stent selection system
US5431679 *10 Mar 199411 Jul 1995United States Surgical CorporationAbsorbable block copolymers and surgical articles fabricated therefrom
US5475063 *14 Dic 199412 Dic 1995United States Surgical CorporationBlends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorbable surgical devices made
US5489297 *2 Nov 19946 Feb 1996Duran; Carlos M. G.Bioprosthetic heart valve with absorbable stent
US5522841 *29 Dic 19944 Jun 1996United States Surgical CorporationHaving blocks of polyalkylene oxide, glycolic acid ester, 1,4-dioxan-2-one randomly polymerized with 1,3-dioxan-2-one
US5527324 *7 Sep 199418 Jun 1996Krantz; Kermit E.Supporting walls of tubular organ during anastomosis
US5542594 *6 Oct 19936 Ago 1996United States Surgical CorporationFor driving surgical fasteners into body tissue
US5551954 *12 Oct 19943 Sep 1996Scimed Life Systems, Inc.Biodegradable drug delivery vascular stent
US5554170 *26 Ene 199510 Sep 1996United States Surgical CorporationPolylactone sutures
US5607474 *20 Sep 19934 Mar 1997Board Of Regents, University Of Texas SystemMulti-phase bioerodible implant/carrier and method of manufacturing and using same
US5618301 *19 Ene 19968 Abr 1997Angiomed AgReducing stent, device with reducing stent and use of a reducing stent
US5618313 *11 Oct 19948 Abr 1997United States Surgical CorporationAbsorbable polymer and surgical articles fabricated therefrom
US5634946 *7 Jun 19953 Jun 1997Focal, Inc.Placing solid, biocompatible, biodegradable polymeric material in contact with tissue surface, then controlled heating to fluidize polymer for coating and cooling to solidify
US5674287 *14 Ene 19947 Oct 1997Endoluminal Therapeutics, Inc.Biodegradable polymeric endoluminal sealing process, apparatus and polymeric product for use therein
US5702656 *7 Jun 199530 Dic 1997United States Surgical CorporationProcess for making polymeric articles
US5749915 *7 Jun 199512 May 1998Focal, Inc.Polymeric endoluminal paving process
US5749922 *7 Jun 199512 May 1998Endoluminal Therapeutics, Inc.Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein
US5800538 *7 Jun 19951 Sep 1998Endoluminal Therapeutics, Inc.Biodegradable polymeric endoluminal sealing process
US5876418 *7 Abr 19972 Mar 1999Angiomed AgDevice for providing a duct in a living body
US5908427 *30 May 19971 Jun 1999United States Surgical CorporationSurgical stapling apparatus and method
US5922022 *31 Dic 199713 Jul 1999Kensey Nash CorporationBifurcated connector system for coronary bypass grafts and methods of use
US5964774 *12 Sep 199712 Oct 1999United States Surgical CorporationSurgical stapling apparatus and method with surgical fabric
US5997568 *17 Ene 19977 Dic 1999United States Surgical CorporationAbsorbable polymer blends and surgical articles fabricated therefrom
US6007565 *5 Sep 199728 Dic 1999United States SurgicalAbsorbable block copolymers and surgical articles fabricated therefrom
US6013853 *15 Feb 199411 Ene 2000The University Of Texas SystemA bioactive agent uniformly distributed in a biodegradable, at least 50%-porous polymer to supply a smooth continuous release the first two weeks of use; release profile promotes migration and differentiation of cells; bones; cartilage
US6017352 *16 Ene 199825 Ene 2000Kensey Nash CorporationSystems for intravascular procedures and methods of use
US6030395 *28 May 199929 Feb 2000Kensey Nash CorporationAnastomosis connection system
US6036705 *1 Jun 199914 Mar 2000Kensey Nash CorporationAnastomosis connection system and method of use
US6045560 *17 Jun 19964 Abr 2000United States Surgical CorporationSurgical stapling apparatus with biocompatible surgical fabric
US6046251 *18 Abr 19974 Abr 2000Kureha Kagaku Kogyo K.K.Biodegradable materials with high impact strength
US6056762 *22 May 19972 May 2000Kensey Nash CorporationAnastomosis system and method of use
US6063114 *4 Sep 199716 May 2000Kensey Nash CorporationConnector system for vessels, ducts, lumens or hollow organs and methods of use
US6136018 *2 Ago 199924 Oct 2000United States Surgical CorporationAbsorbable block copolymers and surgical articles fabricated therefrom
US618367915 Feb 20006 Feb 2001Kureha Kagaku Kogyo, K.K.By charging pellets into an injection molding machine at injection temperature ranging from the melting point of the polymer to 225 degrees c., where the polyglycolic acid has specified melt viscosity, melt enthalpy, and density
US619123610 Oct 199720 Feb 2001United States Surgical CorporationCopolymerizing a mixture of 1,4 dioxane-2-one and 1,3 dioxane-2-one to the point where all the 1,3 dioxane-2-one is incorporated in a polymer but residual 1,4-dioxane-2-one monomer remains, adding glycolide, then block copolymerizing
US6197050 *14 Sep 19986 Mar 2001Heartstent CorporationTransmyocardial implant with compliance collar
US62069083 May 199927 Mar 2001United States Surgical CorporationAbsorbable polymer and surgical articles fabricated therefrom
US62246261 Abr 19991 May 2001Md3, Inc.Ultra-thin expandable stent
US622811127 Sep 19968 May 2001Bionx Implants OyFirst and second degradation and detaching times over longitudinal axis
US62289541 Nov 19948 May 2001United States Surgical CorporationImpact resistance and improved cyclic flex
US62581225 Feb 199710 Jul 2001St. Jude Medical, Inc.Bioresorbable annuloplasty prosthesis
US627389729 Feb 200014 Ago 2001Ethicon, Inc.Surgical bettress and surgical stapling apparatus
US627713618 Feb 199921 Ago 2001General Surgical Innovations, Inc.Method for developing an anatomic space
US627792723 Nov 199821 Ago 2001United States Surgical CorporationComprising blocks consisting of randomly repeating units of lactide and glycolide, wherein the second block contains a larger percentage of lactide units; increased in vivo strength with no decrease in rate of bioabsorption; sutures; fibers
US632581030 Jun 19994 Dic 2001Ethicon, Inc.Foam buttress for stapling apparatus
US63502803 Feb 200026 Feb 2002Kensey Nash CorporationSurgical connector systems and methods of use
US63582669 Oct 199619 Mar 2002General Surgical Innovations, Inc.Active cannulas
US64027676 Mar 200011 Jun 2002Kensey Nash CorporationAnastomosis connection system and method of use
US64097501 Feb 200025 Jun 2002Board Of Regents, The University Of Texas SystemWoven bifurcated and trifurcated stents and methods for making the same
US644394124 Jul 20003 Sep 2002Endoluminal Therapeutics, Inc.Introducing polycaprolactone pliable tube containing living cells into lumen of diseased organ; chemical or physical reconfiguration to mold polymer to wall of cavity; preventing abrupt reclosure or restenosis postangioplasty
US652434522 Oct 199725 Feb 2003Bionx Implants OySurgical implant
US654618813 Ene 19998 Abr 2003Sony CorporationEditing system and editing method
US662352114 Dic 200023 Sep 2003Md3, Inc.Expandable stent with sliding and locking radial elements
US664891120 Nov 200018 Nov 2003Avantec Vascular CorporationMethod and device for the treatment of vulnerable tissue site
US669927213 Dic 20012 Mar 2004Endoluminal Therapeutics, Inc.Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein
US671693225 Jul 20016 Abr 2004Tyco Healthcare Group LpHigh consistency absorbable polymeric resin
US679297916 Sep 200221 Sep 2004Board Of Regents, The University Of Texas SystemMethods for creating woven devices
US68817667 Feb 200319 Abr 2005Tyco Healthcare Group LpSutures and coatings made from therapeutic absorbable glass
US692382019 Feb 20022 Ago 2005Kensey Nash CorporationSurgical connector systems and methods of use
US692669020 Sep 20019 Ago 2005Percardia, Inc.Transmyocardial shunt and its attachment mechanism, for left ventricular revascularization
US695347627 Mar 200011 Oct 2005Neovasc Medical Ltd.Device and method for treating ischemic heart disease
US70184011 Feb 200028 Mar 2006Board Of Regents, The University Of Texas SystemWoven intravascular devices and methods for making the same and apparatus for delivery of the same
US704801416 Sep 200223 May 2006Board Of Regents, The University Of Texas SystemMethods for creating woven devices
US709790730 Jul 200329 Ago 2006United States Surgical Corporationpolydioxanone star polymers used as as fiber coatings, bioadhesives, tissue growth substrate or bone fusion devices
US7163557 *16 Ene 200216 Ene 2007D Eredita RiccardoBiodegradable auricular prosthetic device
US72172735 Dic 200315 May 2007General Surgical Innovations, Inc.Fluid operated retractors
US726462411 Jul 20054 Sep 2007Kensey Nash CorporationSurgical connector systems and methods of use
US73117198 Abr 200325 Dic 2007General Surgical Innovations, Inc.Active cannulas
US732100828 Ago 200622 Ene 2008United States Surgical CorporationBioabsorbable branched polymers end-capped with diketene acetals
US769548331 Ago 200713 Abr 2010Kensey Nash CorporationSurgical connector systems and methods of use
US770427526 Ene 200727 Abr 2010Reva Medical, Inc.Circumferentially nested expandable device
US772266213 Oct 200625 May 2010Reva Medical, Inc.Expandable stent with sliding and locking radial elements
US776306521 Jul 200427 Jul 2010Reva Medical, Inc.Balloon expandable crush-recoverable stent device
US779449022 Jun 200414 Sep 2010Boston Scientific Scimed, Inc.Implantable medical devices with antimicrobial and biodegradable matrices
US7833282 *26 Feb 200716 Nov 2010Mandpe Aditi HEustachian tube device and method
US79145742 Ago 200529 Mar 2011Reva Medical, Inc.Axially nested slide and lock expandable device
US79470719 Oct 200924 May 2011Reva Medical, Inc.Expandable slide and lock stent
US79887214 Dic 20072 Ago 2011Reva Medical, Inc.Axially-radially nested expandable device
US817289426 Abr 20108 May 2012Reva Medical, Inc.Circumferentially nested expandable device
US819248127 Ago 20105 Jun 2012Boston Scientific Scimed, Inc.Implantable medical devices with anti-microbial and biodegradable matrices
US827750020 Jun 20062 Oct 2012Reva Medical, Inc.Slide-and-lock stent
US829294417 Dic 200423 Oct 2012Reva Medical, Inc.Slide-and-lock stent
US837708013 Abr 201019 Feb 2013Kensey Nash CorporationSurgical connector systems and methods of use
US8388616 *27 Feb 20065 Mar 2013Endosmart Gesellschaft Für Medizintechnik MbHCompression sleeve
US841463522 May 20089 Abr 2013Idev Technologies, Inc.Plain woven stents
US841978813 Jul 201216 Abr 2013Idev Technologies, Inc.Secured strand end devices
US846036329 Jul 201111 Jun 2013Reva Medical, Inc.Axially-radially nested expandable device
US849161217 Jun 200923 Jul 2013Covidien LpAnastomosis sheath and method of use
US850658816 Sep 200913 Ago 2013Toby Orthopaedics, Inc.Suture retriever-sheath dilator tool and method for use thereof
US851239426 Jul 201020 Ago 2013Reva Medical Inc.Balloon expandable crush-recoverable stent device
US85239368 Abr 20113 Sep 2013Reva Medical, Inc.Expandable slide and lock stent
US85407627 May 201224 Sep 2013Reva Medical, Inc.Circumferentially nested expandable device
US854554723 May 20111 Oct 2013Reva Medical Inc.Expandable slide and lock stent
US855695421 Oct 200915 Oct 2013Neovasc Medical LtdMethods for treating abnormal growths in the body using a flow reducing implant
US861723528 Mar 201131 Dic 2013Reva Medical, Inc.Axially nested slide and lock expandable device
US86791468 Dic 201125 Mar 2014Toby Orthopaedics, Inc.Method for use of suture retriever-sheath dilator tool
US873938213 Jul 20123 Jun 2014Idev Technologies, Inc.Secured strand end devices
US874743910 Jul 200610 Jun 2014P Tech, LlcMethod of using ultrasonic vibration to secure body tissue with fastening element
US20060149348 *27 Feb 20066 Jul 2006Bernd VogelCompression sleeve
US20110015656 *17 Sep 201020 Ene 2011Eduardo Gonzalez-HernandezDevice for assisting in flexor tendon repair and rehabilitation
EP0158316A2 *9 Abr 198516 Oct 1985Walsh Manufacturing (Mississauga) LimitedAnastomosis devices and kit
EP0199074A1 *17 Mar 198629 Oct 1986American Cyanamid CompanyProcess for manufacturing an annealed prosthetic device
EP0282157A1 *2 Feb 198814 Sep 1988AVANT, Odis LynnStapling apparatus for anastomosis, in particular for urethra-bladder anastomosis
EP0336148A2 *14 Mar 198911 Oct 1989Beiersdorf AktiengesellschaftSurgical implants
EP0480293A1 *1 Oct 199115 Abr 1992LaserSurge, Inc.Clamp for approximating tissue sections
EP0701823A218 Sep 199520 Mar 1996United States Surgical CorporationAbsorbable polymer and surgical articles fabricated therefrom
EP0786259A217 Ene 199730 Jul 1997United States Surgical CorporationAbsorbable polymer blends and surgical articles fabricated therefrom
EP2036582A121 Jul 199518 Mar 2009United States Surgical CorporationBiobsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
EP2301597A121 Jul 199530 Mar 2011United States Surgical CorporationBioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom
WO1987004915A1 *18 Feb 198727 Ago 1987Ekkehard EulerDevice for the macro- and microsurgical junction of vessel ends
WO1994013356A1 *7 Dic 199323 Jun 1994Avatar Design Dev IncAnastomosis stent and stent selection system
WO1997016135A1 *1 Nov 19969 May 1997Peggy T MalikowskiBioresorbable annuloplasty prosthesis
WO1998018408A122 Oct 19977 May 1998Bionix Implants OySurgical implant
WO1999033403A119 Nov 19988 Jul 1999Kensey Nash CorpBifurcated connector system for coronary bypass grafts
WO2004089248A2 *31 Mar 200421 Oct 2004Nachum ErlichStent for use in mammalian anastomosis and method and system for implanting said stent
Clasificaciones
Clasificación de EE.UU.606/154, 623/1.1, 606/155
Clasificación internacionalA61B17/11, D01F6/62, A61F13/15, A61L31/06, A61F13/00, A61B17/00, A61F13/20
Clasificación cooperativaA61F2013/00157, A61F13/551, A61L31/06, D01F6/625, A61B2017/00004, A61B17/11, A61F13/20, A61F2013/00221
Clasificación europeaA61L31/06, D01F6/62B, A61B17/11